Home > Papers

 
 
Anti-Tumor Study of Novel Alkoxylamine analog RGD-Su-AP- PD0325901 Conjugates
HOU Jianjun 1,HE Hongyan 1,LI Xiaoxiao 2,CHEN Zili 2,WU Yun 1 *
1.State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191
2.Department of Chemistry, Renmin University of China, Beijing 100872
*Correspondence author
#Submitted by
Subject:
Funding: Specialized Research Fund for the Doctoral Program of Higher Education（No.20120001120023）, Natural Science Foundation of China （No.81302626）
Opened online:23 July 2015
Accepted by: none
Citation: HOU Jianjun,HE Hongyan,LI Xiaoxiao.Anti-Tumor Study of Novel Alkoxylamine analog RGD-Su-AP- PD0325901 Conjugates[OL]. [23 July 2015] http://en.paper.edu.cn/en_releasepaper/content/4650332
 
 
Peptide-drug conjugation is one of the most promising strategies for the targeting delivery of anti-cancer drug to specific group of cells to minimize the undesirable side effects and achieve the therapeutic effects with a low dose. The ideal peptide carriers induce receptor-mediated internalization by binding to special receptors which are only or more present on the tumor cell surfaces. In our study, we found that RGD peptide conjugated PD0325901 (MEK1/2 inhibitor) had good anti-tumor growth activity on both U87 and MCF-7 cell lines. Especially on U87 cells which are the αvβ3 integrin-positive tumor cells, the dimer RGD conjugate W10 (RGD2-Su-AP-PD) and PEGylated conjugate W11 (RGD-PEG4-Su-AP-PD) showed better inhibition effect than PD0325901. Comparing with the RGD targeting moiety, W10 (with dimer RGD peptide) exhibited significantly higher activity than W4(RGD-Su-AP-PD), and W4 much higher than non-RGD-conjugated W3. And this ability to inhibit the active ERK pathway by conjugates W4 or W10 was blocked by monoclonal antibody of integrin αvβ3 on U87 cells. Comparing with the monomer RGD conjugate W4, Dimer analog W10 showed more target-specific and higher anti-tumor activity. In peptide-drug conjugates, the linker between targeting cargo and pharmacophore is important for the conjugates to bind with cell membrane receptor and allosteric pocket of MEK kinase. Modifications with PEG have been used to enhance the bioavailability and the pharmacokinetic properties of RGD-MEKI conjugate. With the PEG4 linker, the conjugate W11 showed the highest anti-proliferation activity in conjugates. W11 inhibited the DNA replication as same as parent drug/PD0325901.
Keywords:RGD peptide; PD0325901; Integrin αvβ3; RGD-MEKI conjugate; PEG
 
 
 

For this paper
  • ● PDF (0B)
  • ● Revision 0 　　
  • ● Print this paper
  • ● Recommend this paper to a friend
  • ● Add to my favorite list

    Saved Papers

    Please enter a name for this paper to be shown in your personalized Saved Papers list

Tags
Add yours

Related Papers

Statistics
PDF Downloaded 102
Bookmarked 0
Recommend 5
Comments Array
Submit your papers